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Abstract 
Herbalism (also herbal medicine) is a science that includes curing diseases by using plant 
derived compounds. Herbal medicine has important role in curing many diseases and it has 
very long history worldwide. Compared to single constituent dosage medicines, herbal 
medicines exhibit combined therapeutic action and can increase the risk of cytotoxicity caused 
by chemotherapeutic treatments. Proteomic techniques have been applied to study the 
physiology of medicinal plants and their effects on animals to understand the mechanism 
involved in pharmacological nature of plants. This review focus on the present status of 
proteomic research on medicinal plants and covers metabolic pathways involved in synthesis 
of bioactive compounds; pharmacological studies; and proteomics application to indigenous 
plants in disease curing. Pool of proteomic knowledge in a biological and medicinal context can 
boost the effective use of medicinal plants. 
Keywords: Drug, Herbal, Medicinal plants, Protein expression. 
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INTRODUCTION 
The role of medicinal plants is of backbone in herbal 
medicines and biomedical innovation throughout the world. 
Discovery of many conventionally used therapeutic drugs 
based upon the traditional knowledge of medicinal plants 
and further improved by scientific validation. One of the 
remarkable discovery of the world of herbal medicines is 
“Paclitaxel” an anticancerous drug derived from Taxus 
brevifolia (Weaver et al., 2014). A large number of plant-
based potential drug components are still unidentified aside 
from the large-scale screening of herbal products underway 
(Atanasov et al., 2015). These active compounds are difficult 
to identify due to the presence of several other secondary 
metabolites and the complexity of the metabolic pathway 
involved in their biosynthesis (Vogt et al., 2016). 
Environmental effects on genetic and physiological 
responses of plant sum up to the synthesis of secondary 
metabolites. In single plant species, considerable 
differences are found in the biosynthesis of active 
compounds like saponins and flavonoids (Hashiguchi et al., 
2017). Transcription factors play important roles to drive 
different pathways by regulating gene expression (Fatima et 
al., 2018). Chemical reactions cause extensive modifications 
in the biosynthetic pathways of medicinal plants and multiple 
drug compound subfamilies are produced by glycosylation 
steps from branch points of metabolic pathways (Plaza et 
al., 2014). This suggests that for identification of active 
compounds, understanding of the systemic regulation of 
metabolic pathways in medicinal plants is very important. 
Aside from the therapeutics and drug potentials of 
medicinal plants, several compounds, and their biosynthetic 
pathways are undiscovered that can be potential sources of 
the medical field. Many medicinal plants are not known for 
their pharmacological applications. For the proper utilization 
of metabolic products and genetic resources of plants, 
physiological investigations on secondary metabolites 
production and pharmacological effects of active 
compounds on animals are useful directions for future 
studies of medicinal plants. Comprehensive physiological 
information of medicinal plants and animals using these 
plants can be collected by proteomics studies. Discovery of 
key enzymes has explicated the complex metabolic 
pathways of biologically active compounds. Proteomic 
studies depict the changes in physiological activities and 
metabolic pathways caused by external factors. Various 
biological processes were shown responses of animals 
treated with herbal drugs. In medicinal herb’s research, 
these studies are side by side linked to each other. 
Research on medicinal plants can be boosted by increasing 
collaborative multidisciplinary research that includes both 
fields.  
Importance of medicinal plants in drug discovery 
Isolation from natural sources, plants, synthetic 
chemistry etc. are various techniques have been utilized to 
discover the drug compounds further combinatorial natural 
products have proven themselves as new chemical entities 
(NCE) and natural products and their derivatives from 1981 
to 2002 shared 28% of NCEs. Study of natural compounds 
during this time provided another 20% NCEs (Newman et 
al., 2003). So, the research on natural medicinal compounds 
during 1981-2002 reported 48% of NCEs. For the synthesis 
of very challenging new synthetic compounds with multiple 
stereo centers and diverse structures, natural compounds 
provide a starting point (Koehn and Carter, 2005).  Complex 
ring systems, aromatic rings, chiral centers, number and 
ratio of heteroatoms and molecule saturation degree etc. are 
very common to natural drugs and relative to efforts for drug 
discovery (Piggott and Karuso, 2004). Furthermore, with the 
increasing interest in combinatorial chemistry and with the 
realization that these compound libraries are not always 
diverse, many synthetic and medicinal chemists are trying to 
explore the creation of natural-product-like libraries and 
natural products that combine the compound generating a 
potential of combinatorial chemistry with structural features 
of natural products (Tan et al., 2004). Medicinal plants-
based compounds can be used directly as new drugs or 
after some synthetic and medicinal optimizations. Already 
known compounds having new biological activity are good 
drug leads while discovering new drugs from medicinal 
plants when new chemical structures are not found. 
Previous studies documented that plant extracts possess 
antibacterial and antifungal activities (Kalim et al., 2016; 
Hussain et al., 2016; Shahzad et al., 2017; Al-Deen and Al-
Jobory, 2018). 
Sequencing of the human genome revealed the 
importance of thousands of new molecular targets in 
diseases (Kramer and Cohen, 2004). The possible selective 
activity of medicinal plants-based drug compounds may be 
assessed for these target points with the help of high-
throughput screening assays. From traditional medicinal 
plants known drug compounds have shown to act on newly 
identified molecular targets, indirubin is an example that 
selectively acts on cyclin-dependent kinase and inhibits it 
(Eisenbrand et al., 2004) and kamebakaurin inhibits the NF-
nB (Lee et al., 2004). Such responses for many other 
compounds have been noticed that’s increasing the interest 
in the classes of these plant-derived compounds. Examples 
include the; cucurbitacin-I is a diverse set of known 
compounds, obtained from the National Cancer Institute act 
with activated STAT3 selectively inhibits the JAK/STAT3 
pathway in tumors (Blaskovich et al., 2003), cancer cells 
during cell cycle are actively killed by h-lapachone during 
direct checkpoint activation (Li et al., 2003) and with 
activated p38, betulinic acid is selectively cytotoxic to 
melanocytes tumors (Cichewicz and Kouzi, 2004).  
Proteomics and medicine 
Mostly commercial plant species were the focus of 
above mentioned syntenic studies. For mango that 
produces mangier in (a unique xanthonoid) catalog of 
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protein was provided (Andreu et al., 2005). To extract the 
small amount of protein existing in mango pulp and banana, 
protein purification method with more advancement was 
provided by Liao et al. (2016). Proteomics profiles of 
traditionally used medicinal plants Pseudostellaria 
heterophylla, Moringa oleifera and Nigella sativa have 
already been published (Alanazi et al., 2006). Protein 
extraction protocol has optimized for cosmetically important 
seagrass species Posidonia australis and Zostera muelleri 
that contain hundreds of bioactive compounds (Jiang et al., 
2017). A Proteomics study has been carried out for a 
tropical plant Zingiber zerumbet to evaluate the intervention 
of epigenetics in carotenoid biosynthesis (Mahadevan, 
2016). Aside from the elaboration of the physiological 
systematic changes in medicinal plant science, proteomics 
also contributes to identifying the enzymes involved in drug 
compounds production. In Asian countries, commonly used 
herb Centella asiatica has become famous containing 
saponins as active compounds (Gray et al., 2017). Saponin 
is modified by multiple glycosylations; triterpenoid carboxylic 
acid (UDP-glucose 28-O-glucosyltransferase) was 
successfully isolated glycosyltransferase for this modification 
(de Costa et al., 2017). The appropriate use of proteomics 
techniques can help to discover metabolic pathways and 
unique enzymes. Lack of genetic information and the 
complexity of secondary metabolites which is mostly 
species-specific are major constraints for the study of 
medicinal plants. Although genome sequences for some 
species are available (Hodzic et al., 2017), but 
transcriptomics the basis for studying secondary metabolites 
is gaining its importance (Han et al., 2016). Now 
transcriptomics data based on RNA-seq is available for 
many plants including Dendrobium officinale (Shen et al., 
2017), Ephedra sinica (Okada et al., 2016), Polygonum 
minus (Loke et al., 2016), and Dioscorea nipponica (Sun et 
al., 2017). To understand the unique properties of some 
diverse plants like pitcher plant, some tropical and medicinal 
plants were studied by RNA-seq based transcriptomic 
analysis (Zulkipli et al., 2015). Using RNA sequencing high 
throughput sequences are obtained and stored in public 
data repositories which can be reanalyzed (Sansone and 
Bromberg, 2012). 
 
Proteomics and herbal medicines 
The proteomic approach is now used in the treatment of 
many diseases (Figure 1). Proteomics is merging as a new 
area to transform the biology and medicine, mostly protein 
functions are regulated not only by post-translational 
modifications of mRNA but also protein localization, so 
protein expression is poorly correlated with mRNA 
expression (Zaynab et al., 2017a; Zaynab et al., 2018). 
Thus, proteomic studies are concerned to elaborate protein 
expression and functions, to fully understand the working of 
biological systems proteomics will be combined with other 
information including gene profiles and mRNA metabolites. 
Comprehensive knowledge of traditional Chinese medicines 
can be exactly mapped by integrated proteomic 
approaches. Proteomic approaches have been used to 
understand the mode of action and pharmacological effects 
of CTM, in future can be used to identify new bioactive 
compounds and target molecules.  
 
 
Fig. 1.  Proteomics Application in disease curing 
 
Now mass spectrometry-based two techniques are 
being commonly used for quantitative protein profiling 
including proteins labeled with isotope tags separated by 
mass spectrometry and multidimensional liquid 
chromatography and two-dimensional electrophoresis 
followed by mas-spectrometry based staining, identification 
and selection (Figure 2) (Zaynab et al., 2017b;  Weston and 
Hood, 2004). Molecular imaging can supplement both of the 
approaches. In zebra fish flavonoids metabolism from Herba 
epimedii have been studies by the combined use of in vivo 
imaging and proteomic approaches (Li et al., 2011). 
Identification of new species is one of the implications of 
proteomics in CHM as in the case of Panax (P. ginseng vs. 
P. quinquefolium) (Lum et al., 2002). For traditional Chinese 
medicines, proteomics will be a very important tool for 
toxicity studies, quality control, standardization of TCM 
preparations, which are the key points CHM use in the 
western world. Proteomic studies just like transcriptomics 
and genomics have successfully described the mode of 
action of different TCM preparations, as the effect of Si WU 
Tang decoction on the general health (Guo et al., 2014) 
effects of Salvia miltiorrhiza on atherosclerotic lesions (Hung 
et al., 2010), Ganoderma properties in nerve injury (Zhang 
et al., 2014) and the effects of several other preparations in 
cancer have been investigated at the proteomic level (Hung 
et al., 2010).  Further in myocardial ischemia repair effect of 
shuanglong TCM formula on differentiation and use of 
pluripotential cells has also been investigated by proteomics 
data (Fan et al., 2010). Proteomics is becoming an important 
tool for exploring the diverse effects of complex herbal 
preparations, development of active functions, the discovery 
of bioactive compounds, molecular diagnosis and a safe 
prescription for TCM treatments in spite of the difficult 
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interpretation of proteomics due to the inherent complexity of 
the components in TCM decoctions.    
 
 
Fig. 2. Quantitative proteomics in disease curing 
 
CONCLUSION  
Many natural compounds and their metabolic pathways 
that can be important for the medical field are still 
undiscovered. Several pharmaceutical properties of 
medicinal herbs are remaining to elucidate. Physiological 
studies of plant’s secondary metabolites and 
pharmacological effects of plant-based drugs on animals are 
important research areas for utilizing the genetic potential of 
medicinal plants.  Proteomics provides global information on 
medicinal plants and their effects on animals. Discovery of 
key metabolic enzymes has elaborated the complex 
biosynthetic pathways of drug compounds. Proteomic 
approaches have enabled us to understand the 
physiological changes associated with external factors. Plant 
drugs treated animal’s responses elaborated various 
biological pathways. Proteomic studies of secondary 
metabolites and the drug-treated animal’s responses are of 
key importance, and collaborative multidisciplinary research 
can improve the science of medicinal plants. 
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